Indicators on Clinical trial recruitment for ABBV-744 study You Should Know
These side effects ended up notably milder as compared to an inhibitor of the two bromodomains. An in depth molecular Assessment also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes. ― Stephen Taylor- Participant consumed grapefruit or grapefruit products within three days prior to the fi